Bixalomer

DB15200InvestigationalSmall molecule

Bixalomer is under investigation in clinical trial NCT01115985 (A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers).

Mechanism: Pharmacologically active on Phosphate
Curator reviewed
Code names: ASP1585

Resolves to

Compound

UNII3160WY51LVCAS851373-13-2

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which companies are running trials of Bixalomer, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account